G Medical Innovations Holdings Ltd · OTC:GMVDF

G Medical Innovations — IPO Roadshow (June 2019)

31 slides from G Medical Innovations's IPO roadshow presentation, Jun 3, 2019

  1. Slide 1: Company Presentation: A New Era in Healthcare

    The picture can't be displayed. The picture can't be displayed. © 2014 Brightman Almagor Zohar & Co. COMPANY PRESENTATION A NEW ERA IN HEALTHCARE June 2019 Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated June 3 , 2019 Registration No. 333 - 231591

  2. Slide 2: Free Writing Prospectus Statement

    2 This presentation of G Medical Innovations Ltd . (the “ Company ” ) highlights basic information about us and the offering to which this presentation relates . Because it is a summary, it does not contain all of the information that you should consider before investing in our securities . The Comp

  3. Slide 3: Forward Looking Statements

    3 This presentation of the Company contains “ forward - looking statements ” within the meaning of the Private Securities Litigation Reform Act and other securities laws . Words such as “ expects, ” “ anticipates, ” “ intends, ” “ plans, ” “ believes, ” “ seeks, ” “ estimates ” and similar expressio

  4. Slide 4: G Medical Innovations Overview

    G MEDICAL OVERVIEW 1 G MEDICAL INNOVATIONS OVERVIEW 4

  5. Slide 5: G Medical Innovations at a Glance

    G Medical Innovations is at the forefront of the digital health revolution in developing the next generation of mobile technologies that will empower consumers and providers to better monitor, manage, and improve clinical and personal health outcomes. AT A GLANCE • Founded in 2014 • Public company,

  6. Slide 6: The Company's Vision

    6 THE COMPANY ‘ S VISION ENABLING EARLY DETECTION IMPROVING HEALTHCARE OUTCOMES REDUCING COSTS EXPANDING ACCESS TO CLINICALLY RELEVANT INFORMATION + + + G Medical Innovations seeks to usher in a new era of healthcare and wellness by utilizing its patented wireless technologies, and proprietary infor

  7. Slide 7: G Medical: Winning with Experience

    7 G MEDICAL WINNING WITH EXPERIENCE Regulatory approvals • Medical grade devices cleared following FDA and CE guidance • Team experience obtaining clearance with the FDA for over 48 medical devices Go To Market • Over 25 years of medical device development and commercialization Strong R&D • Over 25

  8. Slide 8: Management Team

    MANAGEMENT TEAM Established track record in commercialising medical devices Dr. Yacov Geva President & CEO Dr. Geva is a well - known pioneer in the industry of Medical Devices and remote monitoring services, and co - founder of LifeWatch AG (former Card Guard AG and Card Guard Scientific Survival L

  9. Slide 9: Board of Directors

    BOARD OF DIRECTORS Diverse international Board, with expertise in growth companies Dr. Kenneth R. Melani Chairman  of  the  B oard Dr. Melani has over 30 years ’ experience in the healthcare industry as a provider, supplier and insurer. He has started seven successful for - profit health services

  10. Slide 10: The Market

    THE MARKET 2 10

  11. Slide 11: The Global Healthcare Challenge

    11 THE GLOBAL HEALTHCARE CHALLENGE Source: World Bank, OECD, European Commission Healthcare spending as % of GDP is increasing: • USA: 17 % and rising • OECD: 9 % and rising • EU: 10 % and rising As patients become more demanding and providers ’ constraints more challenging, cost - effective health

  12. Slide 12: The Solution: Mobile Health solutions promise better care and lower costs

    12 • Quality • Convenience • Cost Centralized assets and competencies Remote access to healthcare services – addressing the talent shortage Overall productivity, quality, and convenience gains Standardized, assisted, self - supported care provisioning • Quality • Risk reduction • Cost efficiencies •

  13. Slide 13: Market Sizing

    13 MARKET SIZING Fast growth and adoption of mHealth solutions 41 54 71 92 121 158 2017 2018 2019 2020 2021 2022 In billion USD Source: Variant Market Research IoT devices in healthcare Global mHealth market revenues

  14. Slide 14: The Opportunity – mHealth Market

    Bulk of the global revenues come from services for diagnostic, monitoring, chronic disease management, and antiquated applications. The fastest growing segments have been mobile tools and healthcare apps, which have grown at 26 % and 14 % compound annual growth rate (CAGR) respectively between 2013

  15. Slide 15: Product Suite

    PRODUCT SUITE 3 15

  16. Slide 16: Prizma Sensors: Complete Solution

    © prizma PRIZMA SENSORS Sim; Prizma —— COMPLETE SOLUTION ___

  17. Slide 17: Product Functionality

    Built - in sensors measure ECG, Heart rate, SpO 2 , body temperature and stress (HRV) Manual data entry of weight, glucose measurements and blood pressure. Test , view and store measurements on your smartphone and on the secure Cloud portal PRODUCT FUNCTIONALITY 17

  18. Slide 18: Personal Medical User Portal

    PERSONAL MEDICAL “ USER ” PORTAL Contains Prizma test results, and trending charts Navigate to user settings, testing tutorials and support, set test reminders 18

  19. Slide 19: Personal Medical Doctor Portal

    PERSONAL MEDICAL “ DOCTOR ” PORTAL Doctor ’ s Dashboard Contains Abnormal Test Results, Medical History; Prizma test results; Call History; Physician comments 19 Patient Name Jane Doe

  20. Slide 20: Prizma Report

    PRIZMA REPORT Share your results with any third party from your phone or user portal  20

  21. Slide 21: VSMS Patch - Extended Holter System

    VSMS patch - Extended Holter System, up to 14 days Continuously (beat to beat) records a multi - channel ( 6 leads) ECG and saves the waveforms to SD card. At the end of the service an extended ambulatory report is provided directly to the physician. ▪ Single device with comfortable format enhances

  22. Slide 22: G Medical Prizma – Current & Next Generation

    22 G MEDICAL PRIZMA – CURRENT & NEXT GENERATION x Continues R&D x ECG and Arrhythmia Detection Algorithm – 20 Types of Arrhythmias x SpO 2 Oxygen Saturation Level x Heart Rate x Thermometer – Body Temp x Stress Analysis x External Blood Pressure x External Weight Scale x External Glucose Meter CURRE

  23. Slide 23: Business Model

    BUSINESS MODEL 4 23

  24. Slide 24: Business Model: Prizma and VSMS

    B 86,1(66 M 2'(/  PRIZMA Prizma & Accessories Sales of Products Cloud \ Portal Services Fee Income Call Center Channels B 2 B • Insurance Companies • Medical Institutions • Other Distributors B 2 C • Online Store • Market Places • Patch Unit • Disposables • System Sales of Products Per Patient Use

  25. Slide 25: USA Business Model: The Process

    Patient enrolled on service Insurance coverage verified Patient monitored for up to 30 days 24 / 7 Live Patient Support Urgent / daily reports sent to Physician Summary Report posted Patient returns device IDTF USA BUSINESS MODEL THE PROCESS INCOME BASED ON SERVICE TYPE Extended Holter ( 14 days) Ex

  26. Slide 26: Ambulatory Cardiac Monitoring Offers Significant Opportunity

    26 AMBULATORY CARDIAC MONITORING OFFERS SIGNIFICANT OPPORTUNITY Measure Product Type 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 CAGR ( ’ 15 – ’ 25 ) Mar ket Value ( USD M) Holter Monitors 169 197 231 270 312 355 397 438 476 511 543 12.4 % Event Recorders 321 321 319 316 311 307 302 299 2

  27. Slide 27: U.S.A. Telemetry Device Market 2015–2025

    27 U.S.A. TELEMETRY DEVICE MARKET (USD) 2015 – 2025 n Market Value MARKET VAL U E USD M 0 250 500 750 1000 1250 1500 1750 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Source: Ambulatory Electrocardiography Monitoring Devices | Market Analysis | US | 2017 , Decision Resources Group

  28. Slide 28: Milestones

    MILESTONES 5 28

  29. Slide 29: Investments / IPO

    INVESTMENTS / IPO 29 Source: Management JUNE 17 NOV 17 DEC 17 MAY 17 AUG 18 OCT 18 OCT 18 US$ 5 M Investment received from G Medical JV partner – Chinese fund Guangzhou Sino - Israel Bio Industry Raised AU$ 13.5 M via institutional and sophisticated investor placement Cardiostaff IDTF acquisition US

  30. Slide 30: Regulations

    REGULATIONS 30 Source: Management AUG 17 SEP 17 NOV 17 2020 1 H 2019 NOV 18 CE certification received for Prizma Smartphone Case OTC FDA approval received for Prizma Smartphone Case under prescription 1 H FY 19 CFDA expected approval ( Prizma smartphone case) CE approval received for GMP/VSMS (Exten

  31. Slide 31: Thank You

    D orca Mobility in Healthcare: THANK YOU

G Medical Innovations Holdings — IPO Roadshow (June 2019) on 6ix